The third and final day of ACC.23 featured a key update on Medtronic's pulsed-field ablation technology and many other late-breaking clinical studies. 

The associations were strongest for women who experienced infertility at the age of 25 or younger. 

Catch up on the biggest news that came out of the second day of ACC.23 in New Orleans. 

The conference kicked off with three late-breaking studies that could have a huge impact on patient care going forward. 

One key takeaway was that women faced a higher MI risk than men, but only for the first 30 days. 

The recommendations were developed by a writing group comprised of experts from different specialties, offering an array of perspectives and approaches.

Sahil Parikh, MD, talked to Cardiovascular Business about growing trends related to the treatment of critical lower limb ischemia. "We are getting better and better at saving their limbs, but we are not better at saving their lives," he said. 

The move represents a return of sorts for Pinney, who served Mount Sinai in a variety of leadership roles from 2004 to 2020.